STREAMEX CORP. Current Federal Tax Expense (Benefit)
STREAMEX CORP. (STEX) reported Current Federal Tax Expense (Benefit) of $166.40 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2025-04-15
- STREAMEX CORP. current federal tax expense (benefit) for fiscal 2024 was $166.40M.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $166.40M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |